🇺🇸 Sarepta Therapeutics, Inc.
Forum topic · SRPT · Company page: financials, ownership and filings
Market value
$2.1 B
Automatic updates
2
Mutual funds 1 · Results 1
Member comments
0
approved by an editor
Reactions
0
Join the discussion on Sarepta Therapeutics, Inc.
Loading…
Results announced on 5 November 2026
Sarepta Therapeutics, Inc. announced results on 5 November 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: revenue of $381 million (down 5% from a year earlier) and a net loss of $28 million.
Mutual funds: 259 funds hold $862 million
259 mutual funds in 2 countries hold shares of Sarepta Therapeutics, Inc. worth $862 million, about 45.7% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 166 funds added shares and 109 sold; on balance they bought $118 million. Share splits are not counted as trading.